The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I trial of temozolomide, thalidimide, and lomustine in patients with metastatic melanoma in the brain.
N. E. Papadopoulos
No relevant relationships to disclose
W. Hwu
No relevant relationships to disclose
S. Cain
No relevant relationships to disclose
L. Posada
No relevant relationships to disclose
K. B. Kim
No relevant relationships to disclose
J. Homsi
No relevant relationships to disclose
A. Y. Bedikian
No relevant relationships to disclose
M. A. Davies
No relevant relationships to disclose
P. Hwu
No relevant relationships to disclose